ARCHIVES

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 27 No. 42 | November 16, 2001

Download PDF Visit The Full Archive

Related Articles

Grant Review: NIH Names Members To New Clinical Oncology Review Panel

February 26, 1999

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

July 22, 2011

NCI-Approved Clinical Trials

November 26, 2004

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982